Skip to main content

Rossi Dino A's Form 4 filing

Krystal Biotech, Inc. (KRYS) · filed Aug 14, 2026

Accession no.
0001209059-26-000006
Filed
Aug 14, 2026, 6:22 PM ET
Trade date
Aug 14, 2026
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market sales total $8.23M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rossi Dino ACIK 0001209059Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 14, 2026Common StockGGiftDisposed−3,691$0.00$075,000Direct
Aug 14, 2026Common StockSSaleDisposed−341$325.60−$111,029.0974,659Direct
Aug 14, 2026Common StockSSaleDisposed−2,287$326.60−$746,940.672,372Direct
Aug 14, 2026Common StockSSaleDisposed−5,226$327.39−$1,710,960.5267,146Direct
Aug 14, 2026Common StockSSaleDisposed−1,687$328.52−$554,205.1465,459Direct
Aug 14, 2026Common StockSSaleDisposed−7,428$329.60−$2,448,279.9458,031Direct
Aug 14, 2026Common StockSSaleDisposed−4,896$330.36−$1,617,42253,135Direct
Aug 14, 2026Common StockSSaleDisposed−3,095$331.43−$1,025,786.0650,040Direct
Aug 14, 2026Common StockSSaleDisposed−40$333.23−$13,329.250,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)